{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:44:27Z","timestamp":1788911067754,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.7759\/cureus.87648","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:30:11Z","timestamp":1752136211000},"source":"Crossref","is-referenced-by-count":2,"title":["Is It Time to Consider Hydroxyurea as a Potential Therapeutic Option in the Management of Malignant Pertussis \u2013 A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Abdullah I","family":"Alsharif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef DakheelAllah","family":"Alatawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer Mohammed M","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa469","article-title":"Pertussis (whooping cough)","volume":"224","author":"Decker MD","year":"2021","unstructured":"Decker MD, Edwards KM. Pertussis (whooping cough). J Infect Dis. 2021, 224:S310-20. 10.1093\/infdis\/jiaa469","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30390-0","article-title":"An update of the global burden of pertussis in children younger than 5 years: a modelling study","volume":"17","author":"Yeung KHT","year":"2017","unstructured":"Yeung KHT, Duclos P, Nelson EA, Hutubessy RC. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017, 17:974-80. 10.1016\/S1473-3099(17)30390-0","journal-title":"Lancet Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106174","article-title":"Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China","volume":"88","author":"Shi W","year":"2024","unstructured":"Shi W, Meng Q, Hu Y, Yao K. Modifying antibiotic treatment strategies in the face of pertussis surge associated to erythromycin resistance in China. J Infect. 2024, 88:106174. 10.1016\/j.jinf.2024.106174","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000001013","article-title":"Identifying children at risk of malignant Bordetella pertussis infection","volume":"18","author":"Ganeshalingham A","year":"2017","unstructured":"Ganeshalingham A, McSharry B, Anderson B, Grant C, Beca J. Identifying children at risk of malignant Bordetella pertussis infection. Pediatr Crit Care Med. 2017, 18:e42-7. 10.1097\/PCC.0000000000001013","journal-title":"Pediatr Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00856-y","article-title":"Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study","volume":"11","author":"Coquaz-Garoudet M","year":"2021","unstructured":"Coquaz-Garoudet M, Ploin D, Pouyau R, et al.. Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study. Ann Intensive Care. 2021, 11:70. 10.1186\/s13613-021-00856-y","journal-title":"Ann Intensive Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00261","article-title":"Leukemoid reaction in infant pertussis: is there a place for hydroxyurea? a case report","volume":"6","author":"Maitre G","year":"2018","unstructured":"Maitre G, Schaffner D, Natterer J, et al.. Leukemoid reaction in infant pertussis: is there a place for hydroxyurea? a case report. Front Pediatr. 2018, 6:261. 10.3389\/fped.2018.00261","journal-title":"Front Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001218","article-title":"Hydroxyurea for malignant pertussis in critically ill children","volume":"7","author":"Blanc M","year":"2025","unstructured":"Blanc M, Marais C, Debs A, Cousin VL, Tissi\u00e8res P. Hydroxyurea for malignant pertussis in critically ill children. Crit Care Explor. 2025, 7:e1218. 10.1097\/CCE.0000000000001218","journal-title":"Crit Care Explor"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/C2013-0-23320-1","article-title":"Lanzkowsky's Manual of Pediatric Hematology and Oncology. 6th ed. Academic Press","year":"2016","unstructured":"Lanzkowsky's Manual of Pediatric Hematology and Oncology. 6th ed. Academic Press. Lanzkowsky P, Lipton JM, Fish JD (ed). Academic Press, Cambridge, Massachusetts; 2016. 10.1016\/C2013-0-23320-1"},{"key":"ref9","article-title":"Nathan and Oski\u2019s Hematology of Infancy and Childhood","author":"Nathan DG","year":"2015","unstructured":"Nathan DG, Orkin SH, Ginsburg D, Look AT. Nathan and Oski\u2019s Hematology of Infancy and Childhood. Saunders Elsevier, Philadelphia; 2015."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31828c3bb3","article-title":"Exchange blood transfusion in the management of severe pertussis in young infants","volume":"32","author":"Nieves D","year":"2013","unstructured":"Nieves D, Bradley JS, Gargas J, et al.. Exchange blood transfusion in the management of severe pertussis in young infants. Pediatr Infect Dis J. 2013, 32:698-9. 10.1097\/INF.0b013e31828c3bb3","journal-title":"Pediatr Infect Dis J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008823","article-title":"Severe pertussis infection: a clinicopathological study","volume":"96","author":"Palvo F","year":"2017","unstructured":"Palvo F, Fabro AT, Cervi MC, Aragon DC, Ramalho FS, Carlotti AP. Severe pertussis infection: a clinicopathological study. Medicine (Baltimore). 2017, 96:e8823. 10.1097\/MD.0000000000008823","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.133","article-title":"Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools","volume":"5","author":"Carbonetti NH","year":"2010","unstructured":"Carbonetti NH. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol. 2010, 5:455-69. 10.2217\/fmb.09.133","journal-title":"Future Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2011.08237.x","article-title":"The ins and outs of pertussis toxin","volume":"278","author":"Locht C","year":"2011","unstructured":"Locht C, Coutte L, Mielcarek N. The ins and outs of pertussis toxin. FEBS J. 2011, 278:4668-82. 10.1111\/j.1742-4658.2011.08237.x","journal-title":"FEBS J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31825ba6cf","article-title":"Leukoreduction in patients with severe pertussis with hyperleukocytosis","volume":"31","author":"O\u00f1oro G","year":"2012","unstructured":"O\u00f1oro G, Salido AG, Mart\u00ednez IM, Cabeza B, Gill\u00e9n M, de Azagra AM. Leukoreduction in patients with severe pertussis with hyperleukocytosis. Pediatr Infect Dis J. 2012, 31:873-6. 10.1097\/INF.0b013e31825ba6cf","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case-control study","volume":"61","author":"Winter K","year":"2015","unstructured":"Winter K, Zipprich J, Harriman K, et al.. Risk factors associated with infant deaths from pertussis: a case-control study. Clin Infect Dis. 2015, 61:1099-106. 10.1093\/cid\/civ472","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3264","article-title":"Leukoreduction and hydroxyurea in malignant pertussis: a case series","volume":"8","author":"Aldairi N","year":"2020","unstructured":"Aldairi N, Alali H, Kazzaz Y. Leukoreduction and hydroxyurea in malignant pertussis: a case series. Clin Case Rep. 2020, 8:2705-11. 10.1002\/ccr3.3264","journal-title":"Clin Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pis105","article-title":"Characteristics of severe Bordetella pertussis infection among infants \u226490 days of age admitted to pediatric intensive care units - Southern California, September 2009-June 2011","volume":"2","author":"Murray EL","year":"2013","unstructured":"Murray EL, Nieves D, Bradley JS, et al.. Characteristics of severe Bordetella pertussis infection among infants \u226490 days of age admitted to pediatric intensive care units - Southern California, September 2009-June 2011. J Pediatric Infect Dis Soc. 2013, 2:1-6. 10.1093\/jpids\/pis105","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0b013e31828a70fe","article-title":"Critical pertussis illness in children: a multicenter prospective cohort study","volume":"14","author":"Berger JT","year":"2013","unstructured":"Berger JT, Carcillo JA, Shanley TP, et al.. Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med. 2013, 14:356-65. 10.1097\/PCC.0b013e31828a70fe","journal-title":"Pediatr Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12519","article-title":"Severe pertussis and hyperleukocytosis: is it time to change for exchange?","volume":"54","author":"Kuperman A","year":"2014","unstructured":"Kuperman A, Hoffmann Y, Glikman D, Dabbah H, Zonis Z. Severe pertussis and hyperleukocytosis: is it time to change for exchange?. Transfusion. 2014, 54:1630-3. 10.1111\/trf.12519","journal-title":"Transfusion"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34364","article-title":"Pertussis","volume":"11","author":"Gabutti G","year":"2015","unstructured":"Gabutti G, Azzari C, Bonanni P, Prato R, Tozzi AE, Zanetti A, Zuccotti G. Pertussis. Hum Vaccin Immunother. 2015, 11:108-17. 10.4161\/hv.34364","journal-title":"Hum Vaccin Immunother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2860","article-title":"Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants","volume":"126","author":"Rowlands HE","year":"2010","unstructured":"Rowlands HE, Goldman AP, Harrington K, et al.. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics. 2010, 126:e816-27. 10.1542\/peds.2009-2860","journal-title":"Pediatrics"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13722","article-title":"Biological impact of manual blood exchange in malignant Bordetella pertussis infection in infants","volume":"119","author":"Cousin VL","year":"2024","unstructured":"Cousin VL, Caula C, Tissi\u00e8res P. Biological impact of manual blood exchange in malignant Bordetella pertussis infection in infants. Vox Sang. 2024, 119:1191-5. 10.1111\/vox.13722","journal-title":"Vox Sang"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000490","article-title":"Early complications of hyperleukocytosis and leukapheresis in childhood acute leukemias","volume":"38","author":"Abla O","year":"2016","unstructured":"Abla O, Angelini P, Di Giuseppe G, et al.. Early complications of hyperleukocytosis and leukapheresis in childhood acute leukemias. J Pediatr Hematol Oncol. 2016, 38:111-7. 10.1097\/MPH.0000000000000490","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-012-0917-3","article-title":"Hyperleukocytosis: emergency management","volume":"80","author":"Jain R","year":"2013","unstructured":"Jain R, Bansal D, Marwaha RK. Hyperleukocytosis: emergency management. Indian J Pediatr. 2013, 80:144-8. 10.1007\/s12098-012-0917-3","journal-title":"Indian J Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/genes12071096","article-title":"Hydroxyurea-the good, the bad and the ugly","volume":"12","author":"Musia\u0142ek MW","year":"2021","unstructured":"Musia\u0142ek MW, Rybaczek D. Hydroxyurea-the good, the bad and the ugly. Genes (Basel). 2021, 12:1096. 10.3390\/genes12071096","journal-title":"Genes (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578244","article-title":"Hydroxyurea interaction with \u03b17 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19","volume":"385","author":"Lykhmus O","year":"2023","unstructured":"Lykhmus O, Kalashnyk O, Sullivan R Jr, Skok M. Hydroxyurea interaction with \u03b17 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19. J Neuroimmunol. 2023, 385:578244. 10.1016\/j.jneuroim.2023.578244","journal-title":"J Neuroimmunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2015.1078235","article-title":"A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease","volume":"8","author":"Pule GD","year":"2015","unstructured":"Pule GD, Mowla S, Novitzky N, Wiysonge CS, Wonkam A. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease. Expert Rev Hematol. 2015, 8:669-79. 10.1586\/17474086.2015.1078235","journal-title":"Expert Rev Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000215","article-title":"From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia","volume":"93","author":"Hankins JS","year":"2014","unstructured":"Hankins JS, Aygun B, Nottage K, Thornburg C, Smeltzer MP, Ware RE, Wang WC. From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia. Medicine (Baltimore). 2014, 93:e215. 10.1097\/MD.0000000000000215","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384834-is-it-time-to-consider-hydroxyurea-as-a-potential-therapeutic-option-in-the-management-of-malignant-pertussis---a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:30:12Z","timestamp":1752136212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384834-is-it-time-to-consider-hydroxyurea-as-a-potential-therapeutic-option-in-the-management-of-malignant-pertussis---a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.87648","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}